Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases

Details for Australian Patent Application No. 2007271186 (hide)

Owner Nycomed GmbH

Inventors Wollin, Stefan-Lutz; Wohlsen, Andrea; Braun, Clemens; Marx, Degenhard

Agent Griffith Hack

Pub. Number AU-A-2007271186

PCT Pub. Number WO2008/003701

Priority 06116625.2 05.07.06 EP

Filing date 3 July 2007

Wipo publication date 10 January 2008

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/22 (2006.01)

A61K 31/277 (2006.01)

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/405 (2006.01)

A61K 31/437 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/453 (2006.01)

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 31/505 (2006.01) - Pyrimidines

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/003701 Priority application(s): WO2008/003701

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007271187-Fused bicyclic compounds interacting with the histamine H4 receptor

2007271182-Substituted N-phenylmethyl - 5-oxo-proline-2-amides as P2X7-receptor antagonists and their methods of use